Guo Zi-Fen, He Shu-Ya, Zhu Bing-Yang, Yan Peng-Ke, Li Bin-Yuan, Liao Duan-Fang
Department of Biochemistry, Nanhua University, Hengyang, China.
Sheng Li Xue Bao. 2006 Aug 25;58(4):391-6.
To produce specific monoclonal antibody (McAb) against human thrombomodulin (hTM), the full-length hTM cDNA-expressing plasmid pThr402 was transfected into CHO cells by Lipofectamine 2000 reagent. The hTM-expressing CHO cells, which was confirmed by flow cytometry and Western blot, were obtained by G418 selection. Then the McAb against hTM was prepared with classic hybridoma technique. A cell line of CHO-TM5 with high level of hTM was used to immunize female Balb/c mice 3 times at an interval of 4 weeks. On the third day after the third immunization, mice were sacrificed and spleen cells were harvested to prepare hybridoma cells with SP2/0 cells at the ratio of 10 to 1. Hybridoma cells were then cultured at 96-well plates for screening. Cellular enzyme-linked immunoabsorbent assay (CELISA) was applied twice. The first CELISA was done with polythene ELISA plate with a monolayer of CHO-TM5 cells. The positive clones from the first screen were then selected by reacting with similar screening ELISA plate but with CHO cell monolayer instead. Only clones that were positive for the first screening and negative for the second screening were kept, and called as CHO-TM5(+)CHO(-) hybridoma cells. Balb/c mice were intraperitoneally injected with the selected hybridoma cells. Ascites were collected and monoclonal antibodies were purified using FPLC, and its Ig class, subclass, and titer were then determined respectively. The specificity of the yielded McAb was identified with CELISA, flow cytometry, ABC immunohistochemistry and immunoblotting. One line of hybridoma cells with high expression of specific McAb against hTM, NH-1, was obtained. The Ig subclass of the McAb was IgG1 and the titer of ascitic McAb was 1x10(-6). Flow cytometry, CELISA and Western blot assays demonstrated that McAb NH-1 could specifically recognize hTM expressed in CHO-TM5 cells and human umbilical vascular endothelial cells. Meanwhile, the tissue specificity of antigen recognized by McAb NH-1 was identified by immunohistochemical ABC staining. NH-1 can specifically recognize the natural hTM expressed mainly in vascular endothelial cells, which will potentially be useful for investigation of the functions and clinic values of hTM.
为制备抗人血栓调节蛋白(hTM)的特异性单克隆抗体(McAb),采用Lipofectamine 2000试剂将全长hTM cDNA表达质粒pThr402转染至CHO细胞。通过G418筛选获得经流式细胞术和蛋白质免疫印迹法确认的表达hTM的CHO细胞。然后采用经典杂交瘤技术制备抗hTM的单克隆抗体。用高水平表达hTM的CHO - TM5细胞系以4周的间隔对雌性Balb/c小鼠进行3次免疫。第三次免疫后第三天,处死小鼠并收获脾细胞,以10∶1的比例与SP2/0细胞制备杂交瘤细胞。然后将杂交瘤细胞接种于96孔板中进行培养筛选。应用细胞酶联免疫吸附测定(CELISA)进行两次筛选。第一次CELISA使用包被有单层CHO - TM5细胞的聚乙烯酶标板。第一次筛选出的阳性克隆再与包被有单层CHO细胞的类似筛选酶标板反应进行筛选。仅保留第一次筛选阳性且第二次筛选阴性的克隆,称为CHO - TM5(+)CHO(-)杂交瘤细胞。将筛选出的杂交瘤细胞腹腔注射到Balb/c小鼠体内。收集腹水并用快速蛋白质液相色谱(FPLC)纯化单克隆抗体,然后分别测定其免疫球蛋白类别、亚类和效价。用CELISA、流式细胞术、ABC免疫组织化学和免疫印迹法鉴定所产生单克隆抗体的特异性。获得了一株高表达抗hTM特异性单克隆抗体的杂交瘤细胞系NH - 1。该单克隆抗体的免疫球蛋白亚类为IgG1,腹水单克隆抗体的效价为1×10(-6)。流式细胞术、CELISA和蛋白质免疫印迹分析表明,单克隆抗体NH - 1能特异性识别CHO - TM5细胞和人脐静脉内皮细胞中表达的hTM。同时,通过免疫组织化学ABC染色鉴定了单克隆抗体NH - 1识别的抗原的组织特异性。NH - 1能特异性识别主要在血管内皮细胞中表达的天然hTM,这可能有助于研究hTM的功能和临床价值。